Explore the full record of transactions filed by Attar Eyal C.. Director active across 1 companies, notably Aprea Therapeutics, Inc.. Aggregated, 7 reports have been logged. Total volume traded: €183k. The latest transaction was disclosed on 3 June 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.